" /> Preeclampsia/eclampsia 1 - CISMeF





Preferred Label : Preeclampsia/eclampsia 1;

Symbol : PEE1;

CISMeF acronym : HELLP; PEE; PEE1; PREG1;

Type : Phenotype or locus, molecular basis unknown;

Alternative titles and symbols : Toxemia of pregnancy; PREG1; PEE;

Included titles and symbols : Hypertension, pregnancy-induced; Hemolysis, elevated liver enzymes, and low platelet count; HELLP;

Description : Preeclampsia, which along with chronic hypertension and gestational hypertension comprise the hypertensive disorders of pregnancy, is characterized by new hypertension (blood pressure 140/90 or greater) presenting after 20 weeks' gestation with clinically relevant proteinuria. Preeclampsia is 1 of the top 4 causes of maternal mortality and morbidity worldwide (summary by Payne et al., 2011). Preeclampsia is otherwise known as gestational proteinuric hypertension (Davey and MacGillivray, 1988). A high proportion of patients with preeclampsia have glomerular endotheliosis, the unique histopathologic feature of the condition (Fisher et al., 1981). A distinct form of severe preeclampsia is characterized by hemolysis, elevated liver enzymes, and low platlets (HELLP syndrome) (Brown et al., 2000). - Genetic Heterogeneity of Preeclampsia/Eclampsia Susceptibility loci for preeclampsia/eclampsia include PEE1 on chromosome 2p13, PEE2 (609402) on chromosome 2p25, and PEE3 (609403) on chromosome 9p13. PEE4 (609404) is caused by mutation in the STOX1 gene (609397) on chromosome 10q22. PEE5 (614595) is caused by mutation in the;

Inheritance : Autosomal dominant;

Laboratory abnormalities : Proteinuria; Elevated liver enzymes;

Prefixed ID : %189800;

Details


You can consult :


Nous contacter.
14/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.